Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


It was revealed that in development of a coronary atherosclerosis, participate the immune-mediated mechanisms. In blood of patients with coronary atherosclerosis the maintenance of the basic classes cytokines (IL-1 β, IL-2, IL-6, IL-8, TNF-a) were increased. Development of acute coronary insufficiency is accompanied by additional increase of levels of the data cytokines. The accessory of the cytokine activity to a coronary atherosclerosis was confirmed at studying the maintenance mRNA cytokines in a vascular wall. Thus in a zone atheromatous (aorta) it was synthesized mainly mRNA IL-2, while in a zone lipomatosis (a beam radial artery) it is formed nonspecific immune reaction with development of the mRNA IL-1 and IL-6. For patients with rheumatoid arthritis typically more active defeat of a coronary arteries, in comparison with healthy persons. Chronic immune-mediated process in frameworks of the autoimmune pathology can serve a trigger for accelerated development ischemic heart disease. The General immune-inflammatory mechanisms which participate in pathogenesis of the ischemic heart disease and rheumatoid arthritis, allow to spend the certain parallels between atherosclerotic process and autoimmune pathology.

Full Text

Restricted Access

About the authors

V I Mazurov

North-Western State Medical University named after I.I. Mechnikov

S V Stolov

North-Western State Medical University named after I.I. Mechnikov

I B Belyaeva

North-Western State Medical University named after I.I. Mechnikov

E A Trofimov

North-Western State Medical University named after I.I. Mechnikov


  1. Карпов Р.С., Дудко В.А. Атеросклероз. - Томск: STT, 1998. - 656 с.
  2. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis // Nature. 2011;473:317-325.
  3. Demuth K., Myara I., Moatti N. Biology of the endothelial cell and atherogenesis. [Review] // Annales de Biologie Clinique. - 1995. - 53(4). - P. 171-91.
  4. Wensley F., Gao P., Burgess S., et al. Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data // BMJ. 2011;342:d548.
  5. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A. Recent advances on the role of cytokines in atherosclerosis // Arterioscler Thromb Vasc Biol. 2011;31:969-979.
  6. Moore K.J., Tabas I. Macrophages in the pathogenesis of atherosclerosis // Cell. 2011;145:341-355
  7. Watanabe T., Shimokama T., Haraoka S., Kishikawa H. T lymphocytes in atherosclerotic lesions // Annals of the New York Academy of Sciences. - 1995. - Vol. 748. - Р. 40-55.
  8. Frostegard J., Ulfgren A.K, Nyberg P. et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines // Atherosclerosis. - 1999. - Vol. 145. - Р. 33-43.
  9. Bekkering S., Quintin J., Joosten L. A.B., van der Meer Jos W.M., et al. Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes // Significance Arterioscler Thromb Vasc Biol. 2014;34:8 1731-1738, published online before print June 5 2014, doi: 10.1161/ATVBAHA.114.303887
  10. Shoenfeld Y., Sherer Y., George J., Harats D. Autoantibodies associated with atherosclerosis // Ann. Med. - 2000. - Vol. 32, Suppl., № 1. - Р. 37-40.
  11. Craig W.Y. Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology. [Review]. Journal of Clinical Laboratory Analysis. - 1995. - 9(1). - Р. 70-4.
  12. Stemme S., Faber B., Holm J. et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein // Proceedings of the National Academy of Sciences of the United States of America. - 1995. - Vol. 92, № 9. - Р. 3893-7.
  13. Климов А.Н. Аутоиммунная теория патогенеза и концепция модифицированных липопротеидов // Вест. АМН СССР. - 1990. - № 11. - С. 30-36.
  14. Нагорнев В.А. Атерогенез и иммунное воспаление // Архив патологии. - 1995. - № 3. - С. 6-14.
  15. Hansson G.K. Immune mechanisms in atherosclerosis // Arterioscler. Thromb. Vasc. Biol. - 2001. - Vol. 21. - P. 1876-1890.
  16. Ross R. Atherosclerosis is an inflammatory disease // N. Engl. J. Med. - 1999. - Vol. 340. - P. 115-121.
  17. Hansson G.K., Hermansson A. The immune system in atherosclerosis // Nat Immunol. 2011;12:204-212.
  18. Introna M., Mantovani A. Early activation signals in endothelial cells: stimulation by cytokines // Arterioscler. Thromh. Vase. Biol. - 1997. - Vol. 17. - P. 423-428.
  19. van der Wal A.C., Becker A.E. Immune and inflammatory responses in human atherosclerotic plaque // Schultheiss H., Schwimrnbeck P. eds. The role of immune mechanisms in cardiovascular disease. Berlin. - 1997. - Р. 205-213.
  20. Bekkering S., Joosten L.A., Meer J.W., Netea M.G., et al. Trained innate immunity and atherosclerosis // Curr Opin Lipidol. 2013;24:487-92
  21. Lijnen P.J., Petrov V.V., Fagard R.H. Induction of cardiac fibrosis by transforming growth factor-beta (1) // Mol. Genet. Metab. - 2000. - Vol. 71(1-2). - P. 418-35.
  22. Zernecke A. Weber C. Chemokines in Atherosclerosis: Proceedings Resumed // Arterioscler Thromb Vasc Biol. 2014;34:4 742-750, published online before print January 16 2014, doi: 10.1161/ATVBAHA.113.301655
  23. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways // Physiol Rev. 2006;86:515-581.
  24. Tashiro H., Shimokawa H., Yamamoto K., Momohara M. Altered plasma levels of cytokines in patients with ischemic heart disease // Coron. Artery Dis. - 1997. - Vol. 8, № 3-4. - Р. 143-7.
  25. Тепляков А.И., Кручинский Н.Г., Прищепова Е.В. и др. Роль молекул клеточной адгезии и цитокинов в регуляции межклеточных взаимодействий при атеросклерозе // Ангиология и сосудистая хирургия. - 1999. - Т. 5., № 3. - С. 11-15.
  26. Parissis J., Venetsanou K., Ziras N. Abnormal cytokine expression during the cours of acute myocardial ifarction // Eur. Heart J. - 1998. - Vol.19, Abstr., Suppl. - P.508.
  27. Swirski FK. Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure // Science. 2013;339:161-166.
  28. de Jager S.C., Bot I., Kraaijeveld A.O., Korporaal S.J., et al. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation // Arterioscler Thromb Vasc Biol. 2013;33:e75-e83
  29. Kishikawa H., Shimokama T., Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima: role of cell-mediated immunity in human atherogenesis // Virchows Arch. A. Pathol. Anat. Histopathol. - 1993. - Vol. 423. - P.433-442.
  30. McManus DD, Beaulieu LM, Mick E, Tanriverdi K, et al. Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk // Arterioscler Thromb Vasc Biol. 2013;33:2666-2673.
  31. Nabata T., Fukuo K., Kitano S. et al. IL-2 modulates the responsiveness to angiotensin II in cultured vascular smooth muscle cells // Atherosclerosis. 1997. Vol. 133(1). Р.23-30.
  32. Szekanecz Z., Shah M.R., Pearce W.H. Human atherosclerotic abdomil aortic aneurisms produce IL-6 and IFN-gamma but not IL-2 and IL-4: possible role for IL-6 and IFN-gamma in vascular inflammation // Agents Actions. - 1994. - Vol. 42(3-4). - P. 159-162.
  33. Danesh J., Collins R., Appleby P., Peto R et al. Fibrinogen, C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease // JAMA. - 1998. - Vol. 279. - Р. 1477-1482.
  34. Ridker PM, Howard CP, Walter V, Everett B, Group CPI. Effects of interleukin-1beta inhibition with canakinumab on hemaglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial // Circulation. 2012; 126:2739-2748.
  35. Niu W., Liu Y., Qi Y., Wu Z., et al. Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing Mendelian randomization approach // Int J Cardiol. 2012;157:243-252.



Abstract - 235

PDF (Russian) - 129


Article Metrics

Metrics Loading ...




  • There are currently no refbacks.

Copyright (c) 2015 Mazurov V.I., Stolov S.V., Belyaeva I.B., Trofimov E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies